全文获取类型
收费全文 | 676篇 |
免费 | 45篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 42篇 |
妇产科学 | 2篇 |
基础医学 | 47篇 |
口腔科学 | 8篇 |
临床医学 | 69篇 |
内科学 | 135篇 |
皮肤病学 | 6篇 |
神经病学 | 18篇 |
特种医学 | 229篇 |
外科学 | 39篇 |
综合类 | 32篇 |
预防医学 | 22篇 |
眼科学 | 4篇 |
药学 | 28篇 |
中国医学 | 1篇 |
肿瘤学 | 53篇 |
出版年
2022年 | 1篇 |
2021年 | 7篇 |
2020年 | 7篇 |
2018年 | 4篇 |
2017年 | 5篇 |
2016年 | 8篇 |
2015年 | 8篇 |
2014年 | 5篇 |
2013年 | 12篇 |
2012年 | 5篇 |
2011年 | 8篇 |
2010年 | 17篇 |
2009年 | 25篇 |
2008年 | 10篇 |
2007年 | 17篇 |
2006年 | 11篇 |
2005年 | 17篇 |
2004年 | 8篇 |
2003年 | 18篇 |
2002年 | 12篇 |
2001年 | 8篇 |
2000年 | 9篇 |
1999年 | 14篇 |
1998年 | 46篇 |
1997年 | 49篇 |
1996年 | 39篇 |
1995年 | 22篇 |
1994年 | 42篇 |
1993年 | 30篇 |
1992年 | 9篇 |
1991年 | 16篇 |
1990年 | 11篇 |
1989年 | 30篇 |
1988年 | 23篇 |
1987年 | 19篇 |
1986年 | 26篇 |
1985年 | 14篇 |
1984年 | 16篇 |
1983年 | 14篇 |
1982年 | 15篇 |
1981年 | 24篇 |
1980年 | 6篇 |
1979年 | 6篇 |
1978年 | 9篇 |
1977年 | 12篇 |
1976年 | 11篇 |
1975年 | 10篇 |
1955年 | 1篇 |
1954年 | 1篇 |
排序方式: 共有737条查询结果,搜索用时 15 毫秒
21.
The Science of Salt: A Regularly Updated Systematic Review of the Implementation of Salt Reduction Interventions (November 2015 to February 2016) 下载免费PDF全文
Kathy Trieu MPH Rachael McLean BA MBChB MPH PhD FNZCPHM Claire Johnson MIPH Joseph Alvin Santos BSN Thout Sudhir Raj MA Norm RC. Campbell MD Jacqui Webster PhD 《Journal of clinical hypertension (Greenwich, Conn.)》2016,18(12):1194-1204
The objective of this periodic review was to identify, summarize, and appraise studies relating to the implementation of salt reduction strategies that were retrieved between November 2015 and February 2016. From the established MEDLINE search, 56 studies were identified as relevant to the implementation of salt reduction initiatives. Detailed appraisal was performed on seven studies that evaluated the impact of salt reduction interventions. While study quality varied, all had one or more risks related to bias. There was consistent evidence, from three studies, demonstrating that setting‐based structural interventions to improve the nutritional composition of foods were effective in reducing salt but mixed evidence in relation to the effectiveness of behavioral interventions. The development of an evaluation guidance framework that supports scientific rigor and external validity would aid future design and interpretation of studies evaluating salt reduction interventions, particularly for low‐resource countries. 相似文献
22.
Continuous Cardiac Monitoring around Atrial Fibrillation Ablation: Insights on Clinical Classifications and End Points 下载免费PDF全文
23.
Laura A Hawryluck William RC Harvey Louise Lemieux-Charles Peter A Singer 《BMC medical ethics》2002,3(1):3-9
Background
Intensivists must provide enough analgesia and sedation to ensure dying patients receive good palliative care. However, if it is perceived that too much is given, they risk prosecution for committing euthanasia. The goal of this study is to develop consensus guidelines on analgesia and sedation in dying intensive care unit patients that help distinguish palliative care from euthanasia.Methods
Using the Delphi technique, panelists rated levels of agreement with statements describing how analgesics and sedatives should be given to dying ICU patients and how palliative care should be distinguished from euthanasia. Participants were drawn from 3 panels: 1) Canadian Academic Adult Intensive Care Fellowship program directors and Intensive Care division chiefs (N = 9); 2) Deputy chief provincial coroners (N = 5); 3) Validation panel of Intensivists attending the Canadian Critical Care Trials Group meeting (N = 12).Results
After three Delphi rounds, consensus was achieved on 16 statements encompassing the role of palliative care in the intensive care unit, the management of pain and suffering, current areas of controversy, and ways of improving palliative care in the ICU.Conclusion
Consensus guidelines were developed to guide the administration of analgesics and sedatives to dying ICU patients and to help distinguish palliative care from euthanasia. 相似文献24.
P Rump RC Niessen KT Verbruggen OF Brouwer M de Raad R Hordijk 《Clinical genetics》2011,79(2):183-188
Rump P, Niessen RC, Verbruggen KT, Brouwer OF, de Raad M, Hordijk R. A novel mutation in MED12 causes FG syndrome (Opitz–Kaveggia syndrome). Opitz–Kaveggia syndrome is a rare X‐linked multiple congenital anomalies and intellectual disability disorder caused by the recurrent p.R961W mutation in the MED12 gene. Twenty‐three affected males from 10 families with this mutation in the MED12 gene have been described so far. Here we report on a new family with three affected cousins, in which we identified a novel MED12 mutation (p.G958E). This is the first demonstration that other mutations in this gene can also lead to Opitz–Kaveggia syndrome. The clinical phenotype of these three new cases is reviewed in detail and compared with the previous reported cases. 相似文献
25.
KJ Champion C Bunag AL Estep JR Jones CH Bolt RC Rogers KA Rauen DB Everman 《Clinical genetics》2011,79(5):468-474
Champion KJ, Bunag C, Estep AL, Jones JR, Bolt CH, Rogers RC, Rauen KA, Everman DB. Germline mutation in BRAF codon 600 is compatible with human development: de novo p.V600G mutation identified in a patient with CFC syndrome. BRAF, the protein product of BRAF, is a serine/threonine protein kinase and one of the direct downstream effectors of Ras. Somatic mutations in BRAF occur in numerous human cancers, whereas germline BRAF mutations cause cardio‐facio‐cutaneous (CFC) syndrome. One recurrent somatic mutation, p.V600E, is frequently found in several tumor types, such as melanoma, papillary thyroid carcinoma, colon cancer, and ovarian cancer. However, a germline mutation affecting codon 600 has never been described. Here, we present a patient with CFC syndrome and a de novo germline mutation involving codon 600 of BRAF, thus providing the first evidence that a pathogenic germline mutation involving this critical codon is not only compatible with development but can also cause the CFC phenotype. In vitro functional analysis shows that this mutation, which replaces a valine with a glycine at codon 600 (p.V600G), leads to increased ERK and ELK phosphorylation compared to wild‐type BRAF but is less strongly activating than the cancer‐associated p.V600E mutation. 相似文献
26.
PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies 总被引:7,自引:1,他引:7
27.
28.
NiX HouY YangR TangX SmithR NicholsonRC 《第二军医大学学报》2005,26(4):435-435
Corticotrophin-releasing hormone (CRH) plays a major role in mechanisms controlling human pregnancy and parturition. Gene regulation by progesterone may be a key point in the control of placental CRH production. Studies in primary placental ceils show that antagonism of progesterone activity or production by RU486 or trilostane leads to an increase in CRH promoter activity. This effect can be reversed by the addition of progesterone. Overexpression of progesterone receptor A (PRA) or glucocorticoid receptor resulted in a decrease in CRH promoter activity following progesterone treatment, whereas an increase in promoter activity was observed with overexpressed PR-B. 相似文献
29.
NiX HouY KingBR TangX ReadMA SmithR NicholsonRC 《第二军医大学学报》2005,26(4):385-385
Placental CRH plays a major role in the mechanisms controlling human pregnancy and parturition. Understanding how placental CRH production is regulated is therefore of importance. Previously we have shown that placental expression of CRH peptide and mRNA are inhibited by estrogens, in contrast to the stimulatory effects of estrogen on hypothalamic CRH production. Our current study found that in placental cells cotransfected with a CRH promoter construct and an estrogen receptor-alpha expression vector results in a differential regulation whereby 17beta estradiol (E2) decreased and the putative pure estrogen antagonist, ICI 182780, 相似文献
30.
Rosemary RC McEachan Rebecca J Lawton Cath Jackson Mark Conner Jennifer Lunt 《BMC public health》2008,8(1):326